Selection of blockbuster announcements
1、$JD.com Group-SW (09618.HK) $Mr. Xu Lei, President of the Group, has been appointed as the CEO of the company to replace Mr. Liu Qiangdong.
JD.com Group announced that Xu Lei, president of JD.com Group, will be responsible for day-to-day operation management and report to JD.com Group Chairman Liu Qiangdong as JD.com Group CEO. Liu Qiangdong will devote more energy to long-term strategic design, major strategic decision-making and deployment, young leading personnel training and rural revitalization.
2、$Tencent (00700.HK) $: buy back 785000 shares at a cost of more than HK $300 million on April 6
Tencent paid more than HK $300m to buy back 785000 shares at a price of HK $380.6-HK $384.6 per share on April 6, 2022, according to HKEx filings.
Note: this is the eighth day in a row that Tencent has spent HK $300 million on repurchase.
3、$XIAOMI Group-W (01810.HK) $On April 6, about HK $200 million was used to buy back 14.6158 million shares.
XIAOMI Group announced that on April 6, 2022, the company spent HK $199.5 million to buy back 14.6158 million shares at a repurchase price of HK $13.58-HK $13.70 per share.
4、$BeiGene, Ltd. (06160.HK) $Application for listing permit for new indications of Baize an (tirelizumab injection) is accepted
BeiGene, Ltd. announced on the evening of April 6th that the company has recently received notification from the European Drug Administration that applications for new indications for the treatment of advanced or metastatic esophageal squamous cell carcinoma patients who have previously received systemic chemotherapy and non-small cell lung cancer patients with tirelizumab injection have been accepted.
5、$China Vanke (02202.HK) $The contract sales in the first quarter were 106.5 billion yuan, a decrease of about 40.66% over the same period last year.
China Vanke announced that in March 2022, the company realized a contract sales area of 2.369 million square meters, with a contract sales amount of 41.53 billion yuan, a decrease of about 33.9 percent over the same period last year. From January to March in 2022, the company achieved a total contract sales area of 6.327 million square meters, with a contract sales amount of 106.5 billion yuan, a decrease of about 40.66% compared with the same period last year.
In addition, the company plans to buy back A shares at a price of no more than 2 billion yuan per share at a price of 2 billion to 2.5 billion yuan.
6、$Smoore International Holdings Limited (06969.HK) $The profit and comprehensive income in the first quarter totaled 526.6 million yuan, down 55.3% from the same period last year
Smoore International Holdings Limited announced that the total profit and comprehensive income of the group in the first quarter fell by about 55.3% to 526.6 million yuan compared with the same period last year. The decrease in profit and total comprehensive income during the period was mainly due to the fact that more stringent epidemic control measures were adopted in some areas of Shenzhen in the first quarter of 2022, which had a significant impact on the production and operation of some factories of the Group. As a result, the Group's production and shipping plans in the first quarter were negatively affected, resulting in a negative impact on revenue. In addition, according to the R & D plan and budget formulated by the Group at the beginning of the year, the Group's R & D expenditure increased significantly in the first quarter compared with the same period last year.
Shisiyao Group (02005): Steamyl alcohol dry suspension has been included in the priority review list of the State Drug Administration.
Goliath Pharmaceutical-B (01672) Announces approval of the second FASN inhibitor ASC60 to start clinical trials in China for the treatment of advanced solid tumors
Signed an HBM7022 external license agreement with Platinum Pharmaceutical-B (02142) and AstraZeneca PLC
信达生物(01801)：国家药监局批准达伯坦® 在中国用于既往至少接受过一种系统性治疗 且经检测确认存在有FGFR2融合或重排的晚期、转移性或不可手术切除的胆管癌成人患者的治疗
INNOVENT BIO (01801): the State Drug Administration approved Dabotan ®for the treatment of advanced, metastatic or unresectable cholangiocarcinoma in adults who had received at least one systematic treatment and were confirmed by tests to have FGFR2 fusion or rearrangement.
Minshi Group (00425) plans to set up a joint venture company for water-cooled plate products.
Xiehe New Energy (00182) plans to purchase 950 million yuan of wind power equipment.
Financial report data
China Vanke (02202) first quarter contract sales of 106.5 billion yuan decreased by about 40.66% compared with the same period last year.
Smoore International Holdings Limited (06969) adjusted net profit of about 553 million yuan in the first quarter decreased by 54.9% compared with the same period last year.
Xuhui holding Group (00884) has a contract sales of about 12 billion yuan in March.
Greentown China (03900) has total contract sales of 48.2 billion yuan in the first quarter.
Hopson Development (00754) the total contract sales in the first quarter was about 8.021 billion yuan, down about 21.78% from the same period last year.
Sunac China (01918) realized contract sales of about 22.08 billion yuan in March.
The contract sales of Midea Home (03990) in the first quarter was about 19.98 billion yuan, down 49% from the same period last year.
The pre-sale amount of Agile Group (03383) in the first quarter is about 21.11 billion yuan.
Yuexiu Transportation Infrastructure (01052): the toll income of Guangzhou North second Ring Road reached 65.416 million yuan in February, an increase of 16.7% over the same period last year.
Poly Real Estate Group (00119) accumulated contract sales of about 6 billion yuan in the first three months, down 42% from the same period last year.
The total throughput of Qingang (03369) in the first quarter was 92.46 million tons, down 3.76% from the same period last year.
Zhongjun Group Holdings (01966) March contract sales of 8.01 billion yuan decreased 26% compared with the same period last year.
Total 1577.30GWh of Concord New Energy (00182) increased 11.15% in the first quarter compared with the same period last year.
China Vanke (02202) intends to buy back A shares from 2 billion yuan to 2.5 billion yuan.
CANSINOBIO-B (06185): total repurchase of 325000 A shares by the end of March
Tencent (00700) spent HK $300m to buy back 785000 shares on April 6th.
XIAOMI Group-W (01810) repurchased 14.6158 million shares with a capital of about HK $200 million on April 6th
HSBC Holdings PLC (00005) buys back 3.3453 million shares on April 6th
AIA Group Limited (01299) spent about HK $163 million to buy back 1.9644 million shares
China Feihe Limited (06186) HK $4.0538 million buyback 500000 shares on April 6th
Hysan Societe Generale (00014) HK $3.5047 million buyback 150000 shares on April 6
Fuzhikang Group (02038) invested about HK $211.5 to buy back 2 million shares on April 6.
CNPC (00603) HK $1.8666 million buyback 5 million shares on April 6th
Shanghai Pharmaceutical (02607) raised 13.932 billion yuan net from the controlling shareholder and Yunnan Baiyao private offering of about 853 million shares.
Yixin Group (02858) issues 4.7215 million shares under the share option and share incentive scheme
Wynn Macau (01128) issues 4.1 million shares under the share Award Scheme
ESR Cayman Limited (01821) has issued about 896500 additional shares due to the exercise of his equity.
Change of equity
Ganfeng Lithium (01772) was pledged 19.8 million company shares by shareholder Li Liangbin
Byd Company Limited (01211): 3.17 million shares of the company held by shareholders are released from pledge
China aircraft Leasing (01848) Grants 20.9 million share options
Melco International Development (00200) Grants 933000 New share options
Flat Glass Group (06865): issuance of 4 billion yuan convertible corporate bonds approved
Xuhui holding Group (00884) intends to offer to purchase outstanding notes due in 2022.
China Coal Energy (01898): the first issue of mid-term notes will pay interest on April 13th
China International Capital Corporation (03908): 21 CICC F5 will pay interest on April 13th
China International Capital Corporation (03908): 21 CICC F6 will pay interest on April 13th
Investment and Finance
CNOOC Petrochemical (03983) subscribes for 700 million yuan structured deposit products
Hisense Home Appliances (00921) subscribes for 150 million yuan of financial products
Edit / new